Defining Age-Appropriate Endpoints for Neonates and Infants in Clinical Trials
Defining Age-Appropriate Endpoints for Neonates and Infants in Clinical Trials Designing Age-Appropriate Endpoints in Neonatal and Infant Clinical Trials The Importance of Age-Specific Endpoints Endpoints in clinical trials determine whether a treatment is considered safe and effective. For neonates and infants, these endpoints must reflect the unique physiological, developmental, and disease-specific characteristics of early life….
Read More “Defining Age-Appropriate Endpoints for Neonates and Infants in Clinical Trials” »